SEARCH

SEARCH BY CITATION

References

  • Anyukhovsky, E. P., E. A. Sosunov, A. Plotnikov, R. Z. Gainullin, J. S. Jhang, C. C. Marboe & M. R. Rosen: Cellular electrophysiologic properties of old canine atria provide a substrate for arrhythmogenesis. Cardiovasc. Res. 2002, 54, 462469.
  • Aonuma, S., Y. Kohama, K. Akai, Y. Komiyama, S. Nakajima, M. Wakabayashi & T. Makino: Studies on heart. XIX. Isolation of an atrial peptide that improves the rhythmicity of cultured myocardial cell clusters. Chem. Pharm. Bull. (Tokyo) 1980, 28, 33323339.
  • Axelsen, L., S. Mohammed, A. L. Kjølbye, M. S. Nielsen, N. H. Holstein-Rathlou, O. Jensen, S. Andersen, J. Hennan & M. Stahlhut: Serine 297 and Serine 306: Two New Phosphorylation Sites Involved in the Regulation of Connexin43 during Ischemia. Circulation 2005, 112, II-114.
  • Bayly, P. V., B. H. KenKnight, J. M. Rogers, R. E. Hillsley, R. E. Ideker & W. M. Smith: Estimation of conduction velocity vector fields from epicardial mapping data. IEEE Trans. Biomed. Eng. 1998, 45, 563571.
  • Beardslee, M. A., J. G. Laing, E. C. Beyer & J. E. Saffitz: Rapid turnover of connexin43 in the adult rat heart. Circ. Res. 1998, 83, 629635.
  • Benjamin, E. J., D. Levy, S. M. Vaziri, R. B. D'Agostino, A. J. Belanger & P. A. Wolf: Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994, 271, 840844.
  • Budeus, M., M. Hennersdorf, C. Perings, H. Wieneke, R. Erbel & S. Sack: Prediction of the recurrence of atrial fibrillation after successful cardioversion with P wave signal-averaged ECG. Ann. Noninvasive. Electrocardiol. 2005, 10, 414419.
  • Cheng, Y., K. Mowrey, I. R. Efimov, D. R. Van Wagoner, P. J. Tchou & T. N. Mazgalev: Effects of 2,3-Butanedione monoxime on atrial-atrioventricular nodal conduction in isolated rabbit heart. J. Cardiovasc. Electrophysiol. 1997, 8, 790802.
  • Clarke, T. C., D. Thomas, J. S. Petersen, W. H. Evans & P. E. Martin: The antiarrhythmic peptide rotigaptide (ZP123) increases gap junction intercellular communication in cardiac myocytes and HeLa cells expressing connexin 43. Brit. J. Pharmacol. 2006, in press.
  • Dhein, S., B. D. Larsen, J. S. Petersen & F. W. Mohr: Effects of the New Antiarrhythmic Peptide ZP123 on Epicardial Activation and Repolarization Pattern. Cell Commun. Adhes. 2003, 10, 371378.
  • Dhein, S & T. Tudyka: Therapeutic potential of antiarrhythmic peptides. Cellular coupling as a new antiarrhythmic target. Drugs 1995, 49, 851855.
  • Duthe, F., E. Dupont, F. Verrecchia, I. Plaisance, N. J. Severs, D. Sarrouilhe & J. C. Herve: Dephosphorylation agents depress gap junctional communication between rat cardiac cells without modifying the Connexin43 phosphorylation degree. Gen. Physiol. Biophys. 2000, 19, 441449.
  • Eloff, B. C., E. Gilat, X. Wan & D. S. Rosenbaum: Pharmacological modulation of cardiac gap junctions to enhance cardiac conduction: evidence supporting a novel target for antiarrhythmic therapy. Circulation 2003, 108, 31573163.
  • Elvan, A., X. D. Huang, M. L. Pressler & D. P. Zipes: Radiofrequency catheter ablation of the atria eliminates pacing-induced sustained atrial fibrillation and reduces connexin 43 in dogs. Circulation 1997, 96, 16751685.
  • Furberg, C. D., B. M. Psaty, T. A. Manolio, J. M. Gardin, V. E. Smith & P. M. Rautaharju: Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Amer. J. Cardiol. 1994, 74, 236241.
  • Goldstein, R. N & B. S. Stambler: New antiarrhythmic drugs for prevention of atrial fibrillation. Prog. Cardiovasc. Dis. 2005, 48, 193208.
  • Haugan, K., A. L. Kjølbye, J. K. Hennan & J. S. Petersen: Rotigaptide (ZP123) reverts established atrial conduction velocity slowing. Cell Adhes. Commun. 2005a, 12, 271278.
  • Haugan, K., K. B. Olsen, L. Hartvig, J. S. Petersen, N. H. Holstein-Rathlou, J. Hennan & M. S. Nielsen: The antiarrhythmic peptide analogue ZP123 prevents atrial conduction slowing during metabolic stress. J. Cardiovasc. Electrophysiol. 2005b, 6, 537545.
  • Hayashi, H., C. Wang, Y. Miyauchi, C. Omichi, H. N. Pak, S. Zhou, T. Ohara, W. J. Mandel, S. F. Lin, M. C. Fishbein, P. S. Chen & H. S. Karagueuzian: Aging-related increase to inducible atrial fibrillation in the rat model. J. Cardiovasc. Electrophysiol. 2002, 13, 801808.
  • Hennan, J. K., R. E. Swillo, G. A. Morgan, J. C. Keith, R. G. Schaub, R. P. Smith, H. S. Feldman, K. Haugan, J. Kantrowitz, P. J. Wang, A. Abu-Qare, J. Butera, B. D. Larsen & D. L. Crandall: Rotigaptide (ZP123) prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion injury in open-chest dogs. J. Pharmacol. Exp. Therap. 2005, in press. Epub ahead of print as DOI:10.1124/jpet.105.096933.
  • Herve, J. C & D. Sarrouilhe: Modulation of junctional communication by phosphorylation: protein phosphatases, the missing link in the chain. Biol. Cell 2002, 94, 423432.
  • Hirose, M., Y. Takeishi, T. Miyamoto, I. Kubota, K. R. Laurita & S. Chiba: Mechanism for atrial tachyarrhythmia in chronic volume overload-induced dilated atria. J. Cardiovasc. Electrophysiol. 2005, 16, 760769.
  • Keren, G., T. Etzion, J. Sherez, A. A. Zelcer, R. Megidish, H. I. Miller & S. Laniado: Atrial fibrillation and atrial enlargement in patients with mitral stenosis. Amer. Heart J. 1987, 114, 11461155.
  • Kjølbye, A. L., C. B. Knudsen, T. Jepsen, B. D. Larsen & J. S. Petersen: Pharmacological Characterization of the New Stable Antiarrhythmic Peptide Analog Ac-D-Tyr-D-Pro-D-Hyp-Gly-D-Ala-Gly-NH2 (ZP123): In Vivo and in Vitro Studies. J. Pharmacol. Exp. Therap. 2003, 306, 11911199.
  • Lampe, P. D & A. F. Lau: The effects of connexin phosphorylation in gap junctional communication. Int. J. Biochem. Cell. Biol. 2004, 36, 11711186.
  • Laurita, K. R., S. D. Girouard & D. S. Rosenbaum: Modulation of ventricular repolarization by a premature stimulus. Role of epicardial dispersion of repolarization kinetics demonstrated by optical mapping of the intact guinea pig heart. Circ. Res. 1996, 79, 493503.
  • Laurita, K. R & D. S. Rosenbaum: Interdependence of modulated dispersion and tissue structure in the mechanism of unidirectional block. Circ. Res. 2000, 87, 922928.
  • Liu, Y., C. Cabo, R. Salomonsz, M. Delmar, J. Davidenko & J. Jalife: Effects of diacetyl monoxime on the electrical properties of sheep and guinea pig ventricular muscle. Cardiovasc. Res. 1993, 27, 19911997.
  • Nao, T., T. Ohkusa, Y. Hisamatsu, N. Inoue, T. Matsumoto, J. Yamada, A. Shimizu, Y. Yoshiga, T. Yamagata, S. Kobayashi, M. Yano, K. Hamano & M. Matsuzaki: Comparison of expression of connexin in right atrial myocardium in patients with chronic atrial fibrillation versus those in sinus rhythm. Amer. J. Cardiol. 2003, 91, 678683.
  • Neuberger, H. R., U. Schotten, S. Verheule, S. Eijsbouts, Y. Blaauw, A. Van Hunnik & M. Allessie: Development of a substrate of atrial fibrillation during chronic atrioventricular block in the goat. Circulation 2005, 111, 3037.
  • Ohara, T., Z. Qu, M. H. Lee, K. Ohara, C. Omichi, W. J. Mandel, P. S. Chen & H. S. Karagueuzian: Increased vulnerability to inducible atrial fibrillation caused by partial cellular uncoupling with heptanol. Amer. J. Physiol. 2002, 283, H1116H1122.
  • Rohr, S., J. P. Kucera & A. G. Kleber: Slow conduction in cardiac tissue, I: effects of a reduction of excitability versus a reduction of electrical coupling on microconduction. Circ. Res. 1998, 83, 781794.
  • Rosiak, M., J. Ruta & H. Bolinska: Usefulness of prolonged P-wave duration on signal averaged ECG in predicting atrial fibrillation in acute myocardial infarction patients. Med. Sci. Monit. 2003, 9, MT85MT88.
  • Sato, S., S. Yamauchi, R. B. Schuessler, J. P. Boineau, Y. Matsunaga & J. L. Cox: The effect of augmented atrial hypothermia on atrial refractory period, conduction, and atrial flutter/fibrillation in the canine heart. J. Thorac. Cardiovasc. Surg. 1992, 104, 297306.
  • Sinno, H., K. Derakhchan, D. Libersan, Y. Merhi, T. K. Leung & S. Nattel: Atrial ischemia promotes atrial fibrillation in dogs. Circulation 2003, 107, 19301936.
  • Stahlhut, M., J. S. Petersen, J. Hennan & J. Ramirez: The antiarrhythmic peptide analogue rotigaptide (ZP123) increases connexin43 expression in neonatal rat cardiomyocytes. Cell Comm. Adhes. 2006, in press.
  • Takahashi, N., H. Atsumi, S. Nakada, Y. Takeishi & H. Tomoike: Alterations in the inotropic responses to forskolin and Ca2+ and reduced gene expressions of Ca2+-signaling proteins induced by chronic volume overload in rabbits. Jap. Circ. J. 2000, 64, 861867.
  • Takeishi, Y., A. Bhagwat, N. A. Ball, D. L. Kirkpatrick, M. Periasamy & R. A. Walsh: Effect of angiotensin-converting enzyme inhibition on protein kinase C and SR proteins in heart failure. Amer. J. Physiol. 1999, 276, H53H62.
  • Van Der Velden, H. M., J. Ausma, M. B. Rook, A. J. Hellemons, T. A. Van Veen, M. A. Allessie & H. J. Jongsma: Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat. Cardiovasc. Res. 2000, 46, 476486.
  • Verheule, S., C. A. Van Batenburg, F. E. Coenjaerts, S. Kirchhoff, K. Willecke & H. J. Jongsma: Cardiac conduction abnormalities in mice lacking the gap junction protein connexin40. J. Cardiovasc. Electrophysiol. 1999, 10, 13801389.
  • Verheule, S., E. Wilson, S. Banthia, T. H. Everett, S. Shanbhag, H. J. Sih & J. Olgin: Direction-dependent conduction abnormalities in a canine model of atrial fibrillation due to chronic atrial dilatation. Amer. J. Physiol. 2004, 287, H634H644.
  • Verrecchia, F & J. C. Herve: Reversible blockade of gap junctional communication by 2,3-butanedione monoxime in rat cardiac myocytes. Amer. J. Physiol. 1997, 272, C875C885.
  • Wetzel, U., A. Boldt, J. Lauschke, J. Weigl, P. Schirdewahn, A. Dorszewski, N. Doll, G. Hindricks, S. Dhein & H. Kottkamp: Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiologies. Heart 2005, 91, 166170.
  • Wolf, P. A., R. D. Abbott & W. B. Kannel: Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991, 22, 983988.
  • Xing, D., A. L. Kjølbye, M. S. Nielsen, J. S. Petersen, K. W. Harlow, N. H. Holstein-Rathlou & J. B. Martins: ZP123 Increases Gap Junctional Conductance and Prevents Reentrant Ventricular Tachycardia During Myocardial Ischemia in Open Chest Dogs. J. Cardiovasc. Electrophysiol. 2003, 14, 510520.